Puma Biotechnology Inc Stock, NASDAQ:PBYI
10880 Wilshire Boulevard, Suite 2150, Los Angeles, California 90024-4101
United States of America
Number of Employees: 196
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.